Kaken Pharmaceutical Co Ltd KKPCF
Trading Information
- Previous Close Price
- $28.12
- Day Range
- $26.00–26.00
- 52-Week Range
- $23.65–28.12
- Bid/Ask
- $15.78 / $4,024.50
- Shares Outstanding
- 37.87M
- Market Cap
- $984.58M
- Volume/Avg
- 456 / 438
Key Statistics
- Price/Earnings (Normalized)
- 73.56
- Price/Sales
- 1.97
- Dividend Yield (Trailing)
- 4.60%
- Dividend Yield (Forward)
- 4.60%
- Dividend Payment Schedule
- Jun, Nov
- Total Yield
- 4.95%
Company Profile
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,298
- Website
- https://www.kaken.co.jp
Valuation
Metric | KKPCF |
|---|---|
Price/Earnings (Normalized) | 73.56 |
Price/Book Value | 1.06 |
Price/Sales | 1.97 |
Price/Cash Flow | — |
Price/Earnings
KKPCF
Financial Strength
Metric | KKPCF |
|---|---|
Quick Ratio | 3.23 |
Current Ratio | 4.17 |
Interest Coverage | 201.59 |
Quick Ratio
KKPCF
Profitability
Metric | KKPCF |
|---|---|
Return on Assets (Normalized) | 5.51% |
Return on Equity (Normalized) | 6.67% |
Return on Invested Capital (Normalized) | 6.05% |
Return on Assets
KKPCF
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|Nz&!l%y | LOCK|d<m@H | $70B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|&lMf&PF | LOCK|%rqR% | $47B | |||
| Haleon PLC ADR HLN | LOCK|<TMrg$ | LOCK|>m | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|B@WN#DjN | LOCK|>k | $32B | |||
| Viatris Inc VTRS | LOCK|rDqQmkL | LOCK|dtv | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|^? | LOCK|g!k | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|&$^G%B | LOCK|GMT | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|Ym#q$#! | LOCK|D^ | $3B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|!CqvW! | LOCK|hX%@N | $2B | |||
| Perrigo Co PLC PRGO | LOCK|sNg!W#< | LOCK|Lx! | $2B |